These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2538641)

  • 1. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system.
    Zurbriggen A; Fujinami RS
    J Virol; 1989 Apr; 63(4):1505-13. PubMed ID: 2538641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
    Fujinami RS; Rosenthal A; Lampert PW; Zurbriggen A; Yamada M
    J Virol; 1989 May; 63(5):2081-7. PubMed ID: 2539504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant.
    Zurbriggen A; Yamada M; Thomas C; Fujinami RS
    J Virol; 1991 Feb; 65(2):1023-30. PubMed ID: 1987366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
    Clatch RJ; Lipton HL; Miller SD
    J Immunol; 1986 Feb; 136(3):920-7. PubMed ID: 2416841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells.
    Zurbriggen A; Fujinami RS
    J Virol; 1988 Oct; 62(10):3589-96. PubMed ID: 2843661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis.
    Lindsley MD; Patick AK; Prayoonwiwat N; Rodriguez M
    Mayo Clin Proc; 1992 Sep; 67(9):829-38. PubMed ID: 1434926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
    Cash E; Bandeira A; Chirinian S; Brahic M
    J Immunol; 1989 Aug; 143(3):984-8. PubMed ID: 2545781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic variants are not selected during persistent infection with Theiler's virus.
    Leibowitz JL; Rodriguez M
    Infect Immun; 1983 Jul; 41(1):440-2. PubMed ID: 6190757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice.
    Patick AK; Oleszak EL; Leibowitz JL; Rodriguez M
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2123-32. PubMed ID: 2212994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis.
    Yamada M; Zurbriggen A; Fujinami RS
    J Exp Med; 1990 Jun; 171(6):1893-907. PubMed ID: 1693653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a neutralization site of Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Dec; 56(3):887-95. PubMed ID: 2415718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection.
    Zurbriggen A; Thomas C; Yamada M; Roos RP; Fujinami RS
    J Virol; 1991 Apr; 65(4):1929-37. PubMed ID: 1705992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus.
    Lindsley MD; Rodriguez M
    J Immunol; 1989 Apr; 142(8):2677-82. PubMed ID: 2495323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus.
    Sethi P; Lipton HL
    Br J Exp Pathol; 1983 Feb; 64(1):57-65. PubMed ID: 6301522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype.
    Roos RP; Stein S; Routbort M; Senkowski A; Bodwell T; Wollmann R
    J Virol; 1989 Oct; 63(10):4469-73. PubMed ID: 2476574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains.
    Clatch RJ; Lipton HL; Miller SD
    Microb Pathog; 1987 Nov; 3(5):327-37. PubMed ID: 2849024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
    Rodriguez M; Oleszak E; Leibowitz J
    Crit Rev Immunol; 1987; 7(4):325-65. PubMed ID: 2827957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus.
    Zurbriggen A; Hogle JM; Fujinami RS
    J Exp Med; 1989 Dec; 170(6):2037-49. PubMed ID: 2479706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice.
    Patick AK; Pease LR; David CS; Rodriguez M
    J Virol; 1990 Nov; 64(11):5570-6. PubMed ID: 2214025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus.
    Kurtz CI; Sun XM; Fujinami RS
    Microb Pathog; 1995 Jan; 18(1):11-27. PubMed ID: 7783595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.